Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
pmid27998201-compound-12 | cathepsin b | NA | Preclinical target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Pain[MeSHID:D010146] Malignant Bone Neoplasm[MeSHID:D001859] |
NA | patented | unknown |
pmid27998201-compound-12 | cathepsin f | NA | Patented-recorded target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Pain[MeSHID:D010146] Malignant Bone Neoplasm[MeSHID:D001859] |
NA | patented | unknown |
pmid27998201-compound-12 | cathepsin k | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Pain[MeSHID:D010146] Malignant Bone Neoplasm[MeSHID:D001859] |
NA | patented | unknown |
pmid27998201-compound-12 | cathepsin l | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Pain[MeSHID:D010146] Malignant Bone Neoplasm[MeSHID:D001859] |
NA | patented | unknown |
pmid27998201-compound-12 | cathepsin s | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Pain[MeSHID:D010146] Malignant Bone Neoplasm[MeSHID:D001859] |
NA | patented | unknown |
pmid27998201-compound-12 | cathepsin v | NA | Patented-recorded target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Pain[MeSHID:D010146] Malignant Bone Neoplasm[MeSHID:D001859] |
NA | patented | unknown |
click here to return to the previous page |